Global RNA Methylation Sequencing Market Research Report 2024

RNA methylation is a common phenomenon in both eukaryotes and prokaryotes, which plays a crucial role in regulating multipal biological processes. Antibodies, bisulfite are two most used ingredients to help the sequencing, and contribute to obtain the sequence information and transcripts expression of a specific cell or tissue in a certain state.

The global RNA Methylation Sequencing market was valued at US$ 267 million in 2023 and is anticipated to reach US$ 497.5 million by 2030, witnessing a CAGR of 9.1% during the forecast period 2024-2030.

RNA methylation sequencing, also known as m6A-seq (methylated RNA immunoprecipitation sequencing), is a specialized technique used to study RNA epigenetics and the methylation patterns of RNA molecules. RNA epigenetics, including RNA methylation, has gained significant attention in recent years due to its role in gene regulation, RNA processing, and disease mechanisms. This has driven demand for RNA methylation sequencing technologies. Ongoing advancements in high-throughput sequencing technologies have made RNA methylation sequencing more accessible and cost-effective, enabling researchers to analyze methylation patterns at a transcriptome-wide scale. RNA methylation has been implicated in various diseases, including cancer, neurological disorders, and metabolic conditions. Researchers are using RNA methylation sequencing to investigate the role of RNA modifications in disease mechanisms.

This report aims to provide a comprehensive presentation of the global market for RNA Methylation Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Methylation Sequencing.

Report Scope

The RNA Methylation Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA Methylation Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the RNA Methylation Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation


By Company


Epigentek

Zymo Research

Abcam

BenaGen

Seqhealth

RiboBio

Novogene


Segment by Type


Radioisotope Incorporation

Thin-layer Chromatography

Mass Spectrometry

Differential Enzyme/Chemical-RNA Interactions

Bisulphite RNA Sequencing

Antibody-based Sequencing

Big Data


Segment by Application


Epigenetics Research

Transcriptomics Research

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of RNA Methylation Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Frequently Asked Questions